Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 23 references it cites were found in a registry or an index.

Characteristics of Escitalopram Discontinuation Syndrome: A Preliminary Study

Yasui-Furukori, Norio, Hashimoto, Kojiro, Tsuchimine, Shoko, Tomita, Tetsu, Sugawara, Norio, Ishioka, Masamichi, Nakamura, Kazuhiko · 2016 · Clinical Neuropharmacology

Abstract

Background Antidepressant discontinuation syndrome (ADS) frequently occurs in patients who undergo an abrupt discontinuation of their antidepressant medication. Methods We evaluated 25 consecutive outpatients with depression who discontinued their use of escitalopram. The presence of ADS was evaluated according to the Antidepressants Discontinuation Syndrome checklist. Results Antidepressant discontinuation syndrome was observed in 14 of 25 patients. Frequent symptoms were dizziness (44%), muscle tension (44%), chills (44%), confusion or trouble concentrating (40%), amnesia (28%), and crying (28%). The treatment doses and plasma concentrations of escitalopram were significantly higher in patients with ADS than in patients without ADS. No group differences were observed regarding age, sex, or duration of escitalopram treatment before the discontinuation. Conclusions These findings suggest that a higher dose and lower clearance of escitalopram lead to a higher risk of ADS. Very slow tapering is recommended for all patients.

Overview

Integrity signals

Registry

Crossref · 10.1097/wnf.0000000000000139

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 13

Metadata

Authors
Yasui-Furukori, N., Hashimoto, K., Tsuchimine, S., Tomita, T., Sugawara, N., Ishioka, M., & Nakamura, K.
Affiliations
Hirosaki University (JP)
Venue
Clinical Neuropharmacology
Published
2016-05
Volume
39
Issue
3
Pages
125-127
ISSN
0362-5664 (ISSN-L)
OpenAlex
W2385864113
Cited by
13
References
23
Citations by year
2025: 2 · 2024: 3 · 2022: 2 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 1
FWCI
1.41
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
escitalopram, antidepressant discontinuation syndrome, depression, antidepressant tapering, plasma drug concentration, drug clearance, dizziness, chills
MeSH terms
Adult, Depression, Female, Humans, Japan, Male, Middle Aged, Outpatients, Psychiatric Status Rating Scales

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characteristics of Escitalopram Discontinuation Syndrome: A Preliminary Study. https://app.cochat.ai/papers/10.1097/wnf.0000000000000139
The paper
Yasui-Furukori, N., Hashimoto, K., Tsuchimine, S., Tomita, T., Sugawara, N., Ishioka, M., & Nakamura, K. (2016). Characteristics of Escitalopram Discontinuation Syndrome: A Preliminary Study. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000139

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.